4.3 Review

Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients

Journal

CLEVELAND CLINIC JOURNAL OF MEDICINE
Volume 80, Issue 4, Pages 225-233

Publisher

CLEVELAND CLINIC
DOI: 10.3949/ccjm.80a.12182

Keywords

-

Funding

  1. National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health [UL1TR000439]
  2. NIH roadmap for Medical Research

Ask authors/readers for more resources

The emergence of carbapenem-resistant Enterobacteriaceae (CRE) highlights the importance of effective antibiotics to maintain the safety of our health care system. Clinicians will encounter CRE as a cause of difficult-to-treat and often fatal infections in hospitalized patients. We review the mechanisms of carbapenem resistance, the dissemination and clinical impact of these resistant organisms, and challenges to their detection, treatment, and control.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available